BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Dynamic, proactive, team players, close interactions, supportive
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Feel them close, approachable, team players
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Drama free environment, good camaraderie and team spirit, innovation
Quelle est la meilleure partie de votre programme de rémunération?
Entitled to benefits from day 1 on the job, Amount of Annual Vacations, RRSP contributions
Qu’est-ce qui vous rend le plus heureux au travail?
I am contributing to developing new cellular treatments for intractable diseases that will have a great impact on patients, family and societies. I am working on the professional area I am passionate about and that I studied for, therefore, I apply my knowledge, skills, experience and enjoy my role
Other Employee Reviews for BlueRock Therapeutics
×